article

Spotlighting data in upstream bioprocesses – a recipe for quick and successful cell lines

Posted: 17 September 2019 | | No comments yet

Upstream bioprocessing is the epicentre of biologics development, wherein scientists piece together a series of carefully chosen processes with contributing components and parameters to enable the production of highly effective biotherapeutics. Unjulie Bhanot explains why an effective data management system is vital in this quest for the next big therapeutic.

TO GENERATE pure populations and high yields, organisations invest huge amounts of time, money and resource into defining and refining the expression, culturing, fermentation and harvesting steps of development. In an industry that is anticipated to grow at a CAGR of almost 10 percent,1 the pressure is on to get high quality and effective biotherapeutics to market faster. However, with almost 800 molecules expected in the pipeline over the next 10 years,1 maximising stable drug production at a high concentration with the desired attributes and required quality may prove to be a challenge.

While the ability to use a cell’s inherent machinery as a vehicle for biologics development is beneficial, the cell is designed to produce more than just the product of the desired gene. Accounting for minimal undesirable post-translational protein modification and generation of excessive host cell proteins can mean scientists spend hours of their time qualifying and requalifying their methodologies.











To read this article in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy.


*

*

*

*

*

*

*

*

This content is provided to you for free thanks to the kind support of our sponsor: NanoTemper

Related organisations

Send this to a friend